TGA approves Moderna as adolescent booster An ongoing study demonstrates that the booster produces a similar immune response in this cohort to adults aged 18–25, the regulator says.
Study flags knowledge gaps for shingles vaccine Research suggests that misconceptions remain about the shingles vaccine in use for the Government vaccination program for people over 70.
ATAGI announces COVID booster program for some adolescents The advisory group has said 12–15-year-olds with specified underlying conditions should receive an additional vaccine dose.
ATAGI expands fourth COVID vaccine dose eligibility The immunisation advisory group is now recommending a fourth COVID-19 vaccine dose for people with a range of immunocompromising conditions.
RACGP calls for immediate exemption to 12-month telehealth rule for vulnerable GPs The college is urging the Federal Government to change compliance rules to allow immunocompromised GPs and those in isolation to safely continue caring for patients.
Third COVID vaccine dose recommended for immunocompromised kids Severely immunocompromised children aged 5–11 should receive a third COVID vaccine as part of their primary course, ATAGI says.
How to access Medicare support for third COVID vaccine doses GPs can conduct suitability assessments and administer third doses with the same item numbers used for second doses.
Immunocompromised require third COVID vaccine dose: ATAGI The additional dose is considered part of the primary regimen and is intended to generate an immune response equivalent to the general population.
ATAGI says third vaccine dose ‘likely’ for certain cohorts The advisory body has said ‘severely immunocompromised’ people will be among those expected to require an additional dose.